Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (6750)	7/17/2002 2:14:47 PM
From: David Howe	Read Replies (1) \| Respond to of 52153

<< He also makes a big fuss about relative P/S ratios only to concede a little later that you can't compare these across industries. >> Very annoying article. He compares the P/S ratio of the high margin pharma business with low margin businesses like Walmart and then declares that based on P/S the pharmas are a SELL. The people that stop reading at that point will have been mislead. Then, later in the article he declares his original comparisons completely invalid. No wonder the general public is so confused about valuations. Dave